Author Correction: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates. - Lameijer M; Binderup T; van Leent MMT; Senders ML; Fay F; Malkus J; Sanchez-Gaytan BL; Teunissen AJP; Karakatsanis N; Robson P; Zhou X; Ye Y; et al. (Nature biomedical engineering, 2018)